Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720

Transplantation

Volumn 64, Issue 10, 1997, Pages 1407-1414

  Chueh, Shih Chieh ^a   Tian, Ling ^a   Wang, Min ^a   Wang, Mou Er ^a   Stepkowski, Stanislaw M ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; CYCLOSPORIN A; FINGOLIMOD; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030776195     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00006     Document Type: Article

References (39)

1. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608.
2. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigen on purified erythrocytes. Transplantation 1985; 39: 56.
3. Monaco AP, Wood ML, Maki T, et al. Future strategies in immunosuppression: induction of unresponsiveness to organ allografts in clinical transplantation. Transplant Proc 1989; 21: 3939.
4. Wang M, Stepkowski SM, Wang M, et al. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system. Transplantation 1996; 61: 448.
5. Ito T, Stepkowski SM, Kahan BD. Soluble antigen and cyclosporine-induced specific unresponsiveness in rats. Transplantation 1990; 49: 422.
6. Florence LS, Ito T, Ang K, et al. The synergistic effect of total lymphoid irradiation with extracted donor alloantigen to induce transplantation unresponsiveness. Transplantation 1989; 47: 156.
7. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I MHC molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts. Transplantation 1997; 63: 1490.
8. Wong W, Morris, Wood KJ. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of fully allogeneic cardiac allograft. Transplantation 1996; 62: 1462.
9. Hamashima T, Stepkowski SM, Smith S, et al. Induction of transplantation tolerance by a single intrathymic injection of 3 M KCl extracted donor histocompatibility antigens combined with two doses of anti-rat α/β-T cell receptor monoclonal antibodies. Transplantation 1994; 58: 105.
10. Adachi K, Kohara T, Nakano, et al. Design, synthesis, and structure-activity relationship of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem 1995; 5: 853.
11. Chiba K, Hoshino Y, Suzuki C, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996; 28: 1056.
12. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 1996; 28: 1060.
13. Suzuki S, Enosawa S, Kakefuda T, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200.
14. Kawaguchi T, Hoshino Y, Rahman F, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996; 28: 1062.
15. Masubuchi Y, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplant Proc 1996; 28: 1064.
16. Li X-K, Shinomiya T, Enosawa S, Kakefuda T, Amemiya H, Suzuki S. Induction of lymphocyte apoptosis by a novel immunosuppressant, FTY720: relation with Fas, Bcl-2, and Bax expression. Transplant Proc 1997; 29: 1267.
17. Arbones ML, Ord DC, Ley K, et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1: 247.
18. Hamann A, Andrew DP, Westrich DJ, Holzmann B, Butcher EC. Role of α4-integrins in lymphocyte homing to mucosal tissue in vivo. J Immunol 1994; 152: 3282.
19. Li X-K, Enosawa S, Kakefuda T, Amemiya H, Suzuki S. FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecule ICAM-1 in TNF-α-treated human umbilical vein endothelial cells. Transplant Proc 1997; 29: 1265.
20. a molecules. Transplantation 1996; 62: 1002.
21. u alloantigen. Transplantation 1997; 63: 1373.
22. Horton RM, Cai Z, Ho SN, Pease LR. Gene splicing by overlap extension: tailor made genes using the polymerase chain reaction. Biotechniques 1990; 8: 528.
23. Ono K, Lindsey E. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 517: 225.
24. Duarte AJS, Carpenter CB, Strom TB. Expression of T cell differentiation antigen and Ia on rat cytotoxic T lymphocytes. J Immunol 1982; 128: 580.
25. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614.
26. Liu Z, Williams KP, Chang YH, Smith JA. Immunodominance: a single amino acid substitution without an antigenic site alters intra-molecular selection of T cell determinants. J Immunol 1993; 151: 1852.
27. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen presenting cells. Nature 1993; 363: 156.
28. Janeway CAJ, Dianzani U, Portoles P, et al. Cross-linking and conformational change in T cell receptor: role in activation and in repertoire selection. Cold Spring Harb Symp Quant Biol 1989; 54: 657.
29. Vignali DAA, Strominger JL. Amino acid residues that flank core peptide epitopes and extracellular domains of CD4 modulate differential signaling through the T cell receptor. J Exp Med 1994; 179: 1945.
30. Sloan-Lancaster J, Shaw AS, Rothbard JB, et al. Partial T cell signaling: altered phospho-zeta and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 1994; 79: 913.
31. Hamashima T, Stepkowski SM, Kahan BD. Synergistic effects of 3 M KCl-extracted antigens with cyclosporine or cyclosporine/ rapamycin to prolong heart allograft survival in rats. Transplant Proc 1994; 26: 3053.
32. Padberg WM, Lord RHH, Kupiec-Weglinski JW, et al. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. J Immunol 1987; 139: 1751.
33. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62: 1200.
34. Davies JD, Cobbold SP, Waldmann H. Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance. Transplantation 1997; 63: 1570.
35. Giangrande I, Yamada K, Arn S, Lorf T, Sachs DH, LeGuern C. Selective increase in CD4-positive graft infiltrating mononuclear cells among the infiltrates in class I disparate kidney grafts undergoing rejection. Transplantation 1997; 63: 722.
36. Ferraresso M, Ghobrial R, Stepkowski SM, Kahan BD. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Transplantation 1993; 55: 888.
37. Rada C, Lorenzi R, Powis SJ, et al. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
38. l. Immunogenetics 1994; 39: 447.
39. Wang M, Stepkowski SM, Tian L, Langowski JL, Yu J, Kahan BD. Nucleotide sequences of three distinct clones coding for rat heavy chain class I major histocompatibility antigens. Immunogenetics 1996; 43: 318.